Stocks and Investing
Stocks and Investing
Tue, April 16, 2024
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
[ Tue, Apr 16th 2024
] - WOPRAI
Leland Gershell Upgraded (AVTX) to Buy and Held Target at $35 on, Apr 16th, 2024
Leland Gershell of Oppenheimer, Upgraded "Avalo Therapeutics, Inc." (AVTX) to Buy and Held Target at $35 on, Apr 16th, 2024.
Leland, nor any peers, have made any analyst calls on AVTX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources